Koseler Aylin, Arslan Idris, Sabirli Ramazan, Zeytunluoglu Ali, Kılıç Oğuz, Kilic Ismail Dogu
Department of Biophysics, Pamukkale University Faculty of Medicine, Denizli, Turkey.
Department of Biomedical Engineering, Bülent Ecevit University, Zonguldak, Turkey.
Biomark Med. 2021 Aug;15(12):1035-1042. doi: 10.2217/bmm-2020-0468. Epub 2021 Jul 22.
Nondiabetic patients have been studied to determine whether modest elevations in plasma mannose levels may be associated with a greater incidence of coronary artery disease (CAD). The plasma mannose, lipids (triglyceride, low-density lipoprotein, high-density lipoprotein, very low-density lipoprotein) and lactate dehydrogenase levels were successfully evaluated with respect to subsequent CAD using records of 120 nondiabetic patients and 120 healthy volunteers. CAD was identified from myocardial infarction and new diagnoses of angina. Of 120 patients studied, the plasma mannose, triglyceride, lactate dehydrogenase and very low-density lipoprotein levels of patients were significantly higher than control groups. Our findings showed that elevated baseline mannose in plasma was associated with a progressive risk of CAD with time.
对非糖尿病患者进行了研究,以确定血浆甘露糖水平的适度升高是否可能与冠状动脉疾病(CAD)的更高发病率相关。利用120名非糖尿病患者和120名健康志愿者的记录,成功评估了血浆甘露糖、脂质(甘油三酯、低密度脂蛋白、高密度脂蛋白、极低密度脂蛋白)和乳酸脱氢酶水平与后续CAD的关系。CAD通过心肌梗死和新诊断的心绞痛来确定。在120名研究患者中,患者的血浆甘露糖、甘油三酯、乳酸脱氢酶和极低密度脂蛋白水平显著高于对照组。我们的研究结果表明,血浆中基线甘露糖升高与CAD随时间进展的风险相关。